- Home
- MIST vs CBAT Comparison
MIST vs CBAT Comparison
Compare MIST & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- CBAT
- Stock Information
- Founded
- MIST 2003
- CBAT 1999
- Country
- MIST Canada
- CBAT China
- Employees
- MIST N/A
- CBAT N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- CBAT Industrial Machinery/Components
- Sector
- MIST Health Care
- CBAT Miscellaneous
- Exchange
- MIST Nasdaq
- CBAT Nasdaq
- Market Cap
- MIST 98.1M
- CBAT 71.6M
- IPO Year
- MIST N/A
- CBAT N/A
- Fundamental
- Price
- MIST $0.88
- CBAT $0.79
- Analyst Decision
- MIST Strong Buy
- CBAT
- Analyst Count
- MIST 2
- CBAT 0
- Target Price
- MIST $17.00
- CBAT N/A
- AVG Volume (30 Days)
- MIST 4.5M
- CBAT 160.2K
- Earning Date
- MIST 03-13-2025
- CBAT 03-17-2025
- Dividend Yield
- MIST N/A
- CBAT N/A
- EPS Growth
- MIST N/A
- CBAT N/A
- EPS
- MIST N/A
- CBAT 0.13
- Revenue
- MIST N/A
- CBAT $176,614,609.00
- Revenue This Year
- MIST N/A
- CBAT $32.32
- Revenue Next Year
- MIST $1,105.43
- CBAT $40.34
- P/E Ratio
- MIST N/A
- CBAT $6.08
- Revenue Growth
- MIST N/A
- CBAT N/A
- 52 Week Low
- MIST $0.75
- CBAT $0.77
- 52 Week High
- MIST $2.75
- CBAT $2.08
- Technical
- Relative Strength Index (RSI)
- MIST 30.59
- CBAT 37.09
- Support Level
- MIST $1.86
- CBAT $0.77
- Resistance Level
- MIST $2.36
- CBAT $0.90
- Average True Range (ATR)
- MIST 0.23
- CBAT 0.05
- MACD
- MIST -0.06
- CBAT -0.00
- Stochastic Oscillator
- MIST 7.43
- CBAT 15.54
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.